Pilonidal cyst

L12_PILONIDALCYST

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L05 Hospital discharge: ICD-9 — 685 Cause of death: ICD-10 — L05 Cause of death: ICD-9 — 685 2 out of 7 registries used, show all original rules.	3930
4. Check minimum number of events None	3930
5. Include endpoints None	3930
6. Filter based on genotype QC (FinnGen only)	3930

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L00-L08
Name in latin: Cysta pilonidalis

NAME	L12_PILONIDALCYST
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L05
HD_ICD_9	685
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L05
COD_ICD_9	685
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pilonidal cyst based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37426	10491	26770
Only index persons	36039	10189	25850
Unadjusted period prevalence (%)
Whole population	0.62	0.30	0.75
Only index persons	0.81	0.37	0.99
Median age at first event (years)
Whole population	26.92	24.70	27.76
Only index persons	26.75	24.65	27.58

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3930	1503	2427
Unadjusted period prevalence (%)	0.86	0.51	1.07
Median age at first event (years)	29.25	26.14	31.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3555: Matched controls
35549

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

10649.7

323.0

2029

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

21.5

323.0

1232

853

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

33.2

323.0

474

164

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

1020.6

323.0

1262

6851A

ICD-9 Finland

Pilonidal cyst, Without mention of abscess

+∞

323.0

738

6850A

ICD-9 Finland

Pilonidal cyst, With abscess

+∞

288.5

273

S10

ICPC

Boil/carbuncle

9.8

251.6

543

645

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

23.4

241.6

354

167

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

40.8

239.2

303

QBA10

NOMESCO Finland

Incision of skin of trunk

62.7

205.2

240

9733

FHL

Excision of skin change in operating room or anesthesia

23.2

152.5

223

102

P01AB01

ATC

metronidazole; oral, rectal

2.7

150.0

1512

7741

J01DB01

ATC

cefalexin; oral

3.2

146.5

3098

24047

J01FF01

ATC

clindamycin; systemic

2.7

133.4

1165

5392

SPAT1148

SPAT

Treatment of chronic ulcer or burn

4.4

133.0

539

1397

J01DA01

ATC

[U] cefalexin; systemic

2.4

131.4

2376

16161

L05

ICD-10 Finland

Pilonidal cyst

137.0

124.0

132

9749

FHL

Other measure in this category

67.2

117.7

136

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

7.9

111.7

267

360

S85

ICPC

Pilonidal cyst/fistula

70.8

96.0

110

D95

ICPC

Anal fissure/perianal abscess

17.1

95.2

154

L73.2

ICD-10 Finland

Hidradenitis suppurativa

14.2

93.5

163

120

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

4.7

89.2

327

753

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

10.1

87.0

179

186

K61.0

ICD-10 Finland

Anal abscess

9.1

85.9

187

215

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

6.4

80.1

220

360

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

8.4

78.4

179

223

QBE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of trunk

81.9

71.3

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

5.4

70.3

221

428

S18

ICPC

Laceration/cut

2.0

67.7

1280

7946

K60.3

ICD-10 Finland

Anal fistula

6.8

64.2

168

257

WX320

NOMESCO Finland

Spinalanesthesy

2.2

60.0

710

3602

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.9

54.9

992

5954

9731

FHL

Opening and channeling of the inflammatory site in the operating room or anesthesia

29.8

54.2

N02BE01

ATC

paracetamol; systemic, rectal

1.8

51.2

2776

23438

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

50.9

733

4009

SPAT1146

SPAT

Puncture of abscess or incision of skin

6.9

49.8

128

191

S97

ICPC

Chronic ulcer skin

4.7

49.4

176

390

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

48.4

704

3856

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

10.1

48.0

JHA00

NOMESCO Finland

Anal or perianal incision

7.1

47.1

118

170

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

24.5

45.9

N02AX02

ATC

tramadol; systemic, rectal

1.7

43.5

1246

8548

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

42.4

391

1735

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

41.9

345

1439

QBG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of trunk

67.9

41.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

40.8

1515

11117

A10BA02

ATC

metformin; oral

1.9

40.6

684

3934

J01MA02

ATC

ciprofloxacin; systemic

1.7

40.5

1107

7454

WX110

NOMESCO Finland

Local anesthesy

1.6

39.8

2445

20395

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

37.3

331

1434

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

36.6

510

2717

L72.1

ICD-10 Finland

Trichilemmal cyst

2.8

35.1

245

928

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.6

34.7

279

1145

QBG99

NOMESCO Finland

Other operation for chronic ulcer or fistula of skin

340.3

34.0

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

15.9

33.8

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

32.9

3200

29323

9734

FHL

Excision and local plastic or associated free skin grafting

11.9

32.6

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

31.1

278

1208

WX002

NOMESCO Finland

Sedation and analgesia

1.9

30.1

508

2895

SPAT1262

SPAT

Handing over of treatment supplies

1.9

29.0

485

2753

J01MA12

ATC

levofloxacin; systemic

1.9

28.3

463

2607

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

6.9

28.1

105

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

27.2

588

3626

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

27.0

1037

7461

A10AE04

ATC

insulin glargine; parenteral

2.2

27.0

303

1467

T90

ICPC

Diabetes non-insulin dependent

1.8

26.1

508

3029

9759

FHL

Other measure in this category

60.5

26.0

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

25.2

1189

8930

G47.3

ICD-10 Finland

Sleep apnoea

1.6

25.2

688

4529

N07BA03

ATC

varenicline; oral

2.3

24.9

236

1056

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.7

24.8

179

692

68599

ICD-8 Finland

Pilonidal cyst

11.1

24.3

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.7

24.2

168

635

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

24.0

219

962

QBE05

NOMESCO Finland

Excision of sweat glands or sweat gland bearing skin from trunk

67.9

23.8

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

5.8

23.5

117

J01AA07

ATC

tetracycline; systemic

1.7

23.2

566

3602

A02BC02

ATC

pantoprazole; systemic

1.4

23.1

1765

14523

ABE30

NOMESCO Finland

Excision of dermal sinus

+∞

22.9

M79.6

ICD-10 Finland

Pain in limb

1.5

22.8

957

6969

M01AE02

ATC

naproxen; oral, rectal

1.4

22.8

1769

14578

M01AB05

ATC

diclofenac; systemic, rectal

1.4

22.7

2115

18041

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

22.5

1829

15193

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

22.4

1684

13782

T89

ICPC

Diabetes insulin dependent

2.4

22.3

188

792

E66.8

ICD-10 Finland

Other obesity

2.4

22.2

196

848

6459

FHL

Other measure in this category

18.1

22.1

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

21.2

942

6927

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

21.1

1035

7767

J01AA02

ATC

doxycycline; systemic

1.4

21.0

2316

20220

A10AE05

ATC

insulin detemir; parenteral

2.4

21.0

187

810

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.9

20.7

224

N03AX16

ATC

pregabalin; oral

1.6

20.5

594

3952

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

20.4

1135

8722

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

25.6

20.4

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

20.1

527

3411

QXA05

NOMESCO Finland

Skin division, unspecified location

18.9

19.9

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

19.8

166

700

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

19.3

2416

21385

JHD20

NOMESCO Finland

Incision of fistula-in-ano

5.1

19.1

119

SPAT1153

SPAT

Removal of sutures

1.5

18.9

770

5536

L03.9

ICD-10 Finland

Cellulitis, unspecified

5.1

18.8

117

TNX30

NOMESCO Finland

Soft bandage, unspecified region

4.9

18.6

127

A10AA02

ATC

2.6

18.5

137

538

H04AA01

ATC

glucagon; nasal, parenteral

2.6

18.4

138

548

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

18.3

291

1614

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

18.2

622

4295

J01CF05

ATC

flucloxacillin; systemic

2.8

18.2

121

447

N05BA01

ATC

diazepam; systemic, rectal

1.8

18.2

354

2099

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

18.1

717

5117

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

18.1

804

5879

J01DB05

ATC

cefadroxil; oral

2.4

18.0

159

686

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.4

17.8

149

624

WX290

NOMESCO Finland

Other blockade of nerve

1.4

17.8

1653

13822

S04

ICPC

Lump/swelling localized

1.9

17.7

259

1393

H02AB06

ATC

prednisolone; systemic

1.4

17.5

1223

9735

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

17.5

238

1246

6455

FHL

Perianal fistula surgery

11.5

17.5

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

17.1

763

5577

UJF32

NOMESCO Finland

Coloscopy

1.5

16.9

557

3807

A10BK03

ATC

empagliflozin; oral

2.1

16.8

187

902

N03AX12

ATC

gabapentin; oral

1.7

16.7

379

2350

SPAT1263

SPAT

Sampling

1.4

16.6

1218

9751

N06AB04

ATC

citalopram; systemic

1.5

16.5

573

3963

T82

ICPC

Obesity

2.5

16.4

131

537

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

16.3

1257

10146

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

16.0

338

2049

QWC00

NOMESCO Finland

Reoperation for superficial infection in surgery of skin

10.1

15.9

J01CA04

ATC

amoxicillin; systemic

1.4

15.8

2711

24790

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

15.8

586

4108

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

15.8

285

1649

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

15.6

1575

13234

L02.1

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of neck

9.2

15.6

N05AH02

ATC

clozapine; systemic

2.7

15.6

109

417

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

15.5

151

685

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

15.5

445

2939

SPAT1310

SPAT

Counselling related to known health issue

1.4

15.5

857

6516

C08CA01

ATC

amlodipine; oral

1.5

15.4

639

4588

A10AA01

ATC

2.5

15.4

125

520

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

15.3

320

1935

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.6

15.3

114

451

M03BX02

ATC

tizanidine; oral

1.3

15.3

1980

17261

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

8.3

15.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

15.1

161

761

K61

ICD-10 Finland

Abscess of anal and rectal regions

20.1

15.1

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.9

15.0

M54.5

ICD-10 Finland

Low back pain

1.4

15.0

960

7483

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

14.9

176

871

N05AH04

ATC

quetiapine; oral

1.5

14.9

548

3830

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

14.9

2399

21572

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

14.9

627

4513

S29

ICPC

Skin symptom/complaint other

1.6

14.7

385

2479

L03

ICPC

Low back symptom/complaint

1.5

14.6

630

4557

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

14.4

1928

16817

ZZR00

NOMESCO Finland

Flap of skin

3.9

14.3

150

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

6.3

14.2

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.7

14.2

296

1789

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.2

14.2

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.2

14.1

230

EBA00

NOMESCO Finland

Extraction of tooth

1.4

14.1

1036

8250

8201

FHL

Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis

6.2

14.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

14.0

616

4470

N05AA02

ATC

levomepromazine; systemic

2.3

14.0

135

611

N05BA04

ATC

oxazepam; oral

1.5

13.9

626

4561

A46

ICD-10 Finland

Erysipelas

1.7

13.9

288

1740

S76

ICPC

Skin infection other

2.3

13.8

124

544

J02AC01

ATC

fluconazole; systemic

1.4

13.8

968

7644

E66

ICD-10 Finland

Obesity

2.2

13.6

143

672

N03AG01

ATC

valproic acid; systemic, rectal

1.9

13.6

203

1102

K02.1

ICD-10 Finland

Caries of dentine

1.3

13.6

1966

17277

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

13.5

152

737

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

13.5

702

5256

SPAT1301

SPAT

No procedures

1.4

13.5

773

5891

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.9

13.5

139

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.6

13.3

357

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.6

13.3

390

2586

QDA10

NOMESCO Finland

Incision of skin of lower limb

9.7

13.2

M25.5

ICD-10 Finland

Pain in joint

1.4

13.1

766

5854

K61.2

ICD-10 Finland

Anorectal abscess

13.0

12.9

N03AX09

ATC

lamotrigine; oral

1.9

12.9

179

945

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

12.8

546

3931

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.0

12.7

127

SPAT1211

SPAT

Application of soft bandage

1.8

12.7

216

1227

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

12.6

414

2817

6804

FHL

Removal of sacrococcygeal teratoma

130.4

12.4

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

12.4

108

465

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

12.3

308

1961

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

12.2

288

1806

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

12.1

985

7932

C07AB07

ATC

bisoprolol; oral

1.3

12.1

884

7002

A06AD11

ATC

lactulose; oral

1.7

12.1

239

1423

K04.0

ICD-10 Finland

Pulpitis

1.6

12.0

366

2447

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.0

810

6329

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.9

11.8

238

C03CA01

ATC

furosemide; systemic

1.6

11.7

358

2391

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

11.7

186

1034

N06AX16

ATC

venlafaxine; oral

1.5

11.7

415

2871

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

11.6

392

2681

B01AB05

ATC

enoxaparin; parenteral

1.4

11.4

610

4580

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

11.4

317

2074

C09AA05

ATC

ramipril; oral

1.5

11.3

420

2936

UJH02

NOMESCO Finland

Anoscopy

2.2

11.2

112

520

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

11.1

240

1466

D10BA01

ATC

isotretinoin; oral

1.6

11.1

283

1812

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

11.1

546

4036

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.9

11.0

227

N06AB06

ATC

sertraline; oral

1.6

11.0

323

2141

M01AX17

ATC

nimesulide; oral

1.4

10.8

477

3449

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.2

10.7

169

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

10.7

427

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

10.7

113

538

Z72.0

ICD-10 Finland

Tobacco use

2.5

10.7

351

N05CF01

ATC

zopiclone; oral

1.4

10.6

694

5382

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.7

10.6

123

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.7

10.6

256

L72.0

ICD-10 Finland

Epidermal cyst

3.7

10.5

119

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

10.5

279

1803

SPAT1216

SPAT

Assessment of functional ability

1.6

10.5

244

1521

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

10.5

1067

8833

Z71.8

ICD-10 Finland

Other specified counselling

1.4

10.5

666

5141

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

10.4

157

ZXA05

NOMESCO Finland

Left side

1.4

10.4

511

3774

L15

ICPC

Knee symptom/complaint

1.4

10.3

442

3176

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

9.6

10.2

SPAT1254

SPAT

Administration of medicine

1.5

10.2

313

2097

N05AX12

ATC

aripiprazole; systemic

1.8

10.2

167

939

J01FA06

ATC

roxithromycin; oral

1.3

10.1

1050

8704

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

10.1

441

3179

N05AF03

ATC

chlorprothixene; systemic

2.3

10.1

413

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.5

10.1

299

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

10.0

388

2731

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

10.0

328

J01AA04

ATC

lymecycline; systemic

1.5

10.0

394

2786

A02BC05

ATC

esomeprazole; systemic

1.3

10.0

987

8132

M01AH05

ATC

etoricoxib; oral

1.3

10.0

1720

15188

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

9.9

156

865

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.5

9.9

126

L17

ICPC

Foot/toe symptom/complaint

1.4

9.9

550

4147

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

9.9

121

613

R03AC02

ATC

salbutamol; inhalant

1.3

9.9

1493

12976

A10BB12

ATC

glimepiride; oral

2.2

9.9

447

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

9.8

1701

15013

N05AH03

ATC

olanzapine; systemic

1.7

9.8

217

1336

A28

ICPC

Limited function/disability NOS

1.7

9.8

180

1052

N06AX11

ATC

mirtazapine; oral

1.3

9.8

832

6709

A03

ICPC

Fever

1.4

9.7

521

3903

N05CD07

ATC

temazepam; oral

1.7

9.7

195

1170

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

9.6

227

1425

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

9.6

288

1919

SPAT1255

SPAT

Intravenous administration of medicine

1.9

9.5

141

766

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

9.5

304

2054

A02BC03

ATC

lansoprazole; oral

1.4

9.5

623

4826

R06.0

ICD-10 Finland

Dyspnoea

1.4

9.4

498

3726

L72.9

ICD-10 Finland

Follicular cyst of skin and subcutaneous tissue, unspecified

5.8

9.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

9.3

783

6295

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

9.3

285

1909

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

9.3

494

3696

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

9.2

479

3565

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.5

9.2

326

2254

N05AN01

ATC

lithium; oral

2.2

9.1

384

L70.0

ICD-10 Finland

Acne vulgaris

2.0

9.1

117

604

L68.0

ICD-10 Finland

Hirsutism

4.6

9.1

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

9.0

1142

9680

J01DA06

ATC

[U] cefuroxime; systemic

1.4

9.0

382

2741

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

9.0

159

918

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

9.0

333

2323

AA1AD

NOMESCO Finland

CT of head and brain

1.4

9.0

452

3349

WX722

NOMESCO Finland

PEEP

2.0

8.9

109

551

N06AX21

ATC

duloxetine; oral

1.5

8.9

273

1826

C10AA01

ATC

simvastatin; oral

1.3

8.9

665

5250

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.8

8.9

188

J01XC01

ATC

fusidic acid; systemic

3.3

8.9

127

N05AX08

ATC

risperidone; systemic

1.6

8.9

202

1256

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.2

8.8

377

5651A

ICD-9 Finland

Anal fissure and fistula, Anal fistula[FISTULA ANI]

8.0

8.8

-1

NOMESCO Finland

1.3

8.8

1076

9075

C07AA05

ATC

propranolol; systemic

1.4

8.8

513

3896

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.1

8.8

471

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

5.1

8.8

C10AA05

ATC

atorvastatin; oral

1.3

8.7

674

5346

S21

ICPC

Skin texture symptom/complaint

1.5

8.7

260

1732

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.9

8.6

180

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

8.6

347

ACC51

NOMESCO Finland

Release of median nerve

1.7

8.6

162

951

L84

ICD-10 Finland

Corns and callosities

2.3

8.5

322

J04BA02

ATC

dapsone; oral

6.4

8.5

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

8.4

329

2323

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.4

8.4

340

2417

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

8.4

251

1669

N05BA12

ATC

alprazolam; oral

1.5

8.4

242

1600

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.9

8.4

121

653

K08.3

ICD-10 Finland

Retained dental root

1.7

8.3

161

958

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

8.3

488

3714

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

8.2

304

2124

A10BH01

ATC

sitagliptin; oral

1.7

8.2

160

951

L02

ICPC

Back symptom/complaint

1.6

8.1

232

1529

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

8.1

379

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

8.1

413

3064

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

8.1

766

6248

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

8.1

214

1385

K61.1

ICD-10 Finland

Rectal abscess

6.8

8.0

N76.4

ICD-10 Finland

Abscess of vulva

6.8

8.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

8.0

226

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

8.0

106

553

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

8.0

255

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

7.9

104

544

L14

ICPC

Leg/thigh symptom/complaint

1.8

7.9

140

810

M01AC06

ATC

meloxicam; systemic, rectal

1.3

7.9

847

7017

1413

FHL

Laparoscopy and other therapeutic procedure

3.2

7.9

123

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

7.8

549

4288

SPAT1260

SPAT

Consultation of another employee

1.4

7.8

391

2891

N06AA09

ATC

amitriptyline; systemic

1.6

7.8

178

1106

R60.0

ICD-10 Finland

Localized oedema

1.6

7.8

178

1110

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.2

7.7

325

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.4

7.7

255

H03AA01

ATC

levothyroxine sodium; systemic

1.4

7.7

425

3195

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.4

7.7

256

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

7.7

430

M48.0

ICD-10 Finland

Spinal stenosis

1.7

7.7

167

1024

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

7.7

188

R51.80

ICD-10 Finland

Headache

1.4

7.6

404

3015

N05AB03

ATC

perphenazine; systemic, rectal

1.9

7.6

107

572

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

7.6

376

2773

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

7.6

307

2181

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

7.6

369

2719

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

7.5

355

2596

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

7.5

284

R06.5

ICD-10 Finland

Mouth breathing

1.5

7.5

244

1659

SGB20

NOMESCO Finland

Filling of root of tooth with 2 root channels

1.6

7.5

200

1296

A10AE06

ATC

insulin degludec; parenteral

1.9

7.5

100

527

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.5

7.4

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

7.4

463

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

7.4

410

3083

A02BC01

ATC

omeprazole; systemic

1.3

7.4

565

4464

H3600, E103

ICD-10 Finland

2.5

7.4

222

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

13.4

7.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

7.4

645

5199

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.7

7.4

181

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2.3

7.4

289

L03.3

ICD-10 Finland

Cellulitis of trunk

5.6

7.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

7.3

160

985

C05.9

ICD-10 Finland

Malignant neoplasm: Palate, unspecified

+∞

7.3

6463

FHL

Perineal or sacroperineal plastics

+∞

7.3

6805A

ICD-9 Finland

Carbuncle and furuncle, Buttock

+∞

7.3

R53

ICD-10 Finland

Malaise and fatigue

1.3

7.3

449

3439

SPAT1283

SPAT

Restricted health certificate

1.3

7.3

669

5424

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.4

7.3

292

2073

P99

ICPC

Psychological disorders other

1.9

7.3

517

S01

ICPC

Pain/tenderness of skin

2.0

7.2

476

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.7

7.2

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

7.2

132

774

R50.9

ICD-10 Finland

Fever, unspecified

1.4

7.2

340

2488

H3601, E103

ICD-10 Finland

2.6

7.1

180

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

3.4

7.1

J01MA01

ATC

ofloxacin; systemic

1.6

7.1

161

1005

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.4

7.1

224

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.6

7.0

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

7.0

427

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.1

7.0

378

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

7.0

554

4405

SPAT1240

SPAT

Therapeutic discussion

1.4

6.9

339

2498

N03AF01

ATC

carbamazepine; oral, rectal

1.8

6.9

111

625

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

6.9

154

956

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.7

6.9

171

R03BB04

ATC

tiotropium bromide; inhalant

1.7

6.9

144

878

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

6.8

480

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

6.8

217

1470

QBB10

SPAT

6.7

6.8

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.5

6.8

190

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

6.8

177

1142

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

6.8

140

851

L16

ICPC

Ankle symptom/complaint

1.5

6.8

228

1564

D07AC01

ATC

betamethasone; topical

1.2

6.8

827

6940

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

6.7

195

1291

C09AA02

ATC

enalapril; systemic

1.4

6.7

312

2274

N05AA01

ATC

chlorpromazine; systemic, rectal

2.7

6.7

167

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

6.7

975

8342

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.7

718

5931

WZC30

NOMESCO Finland

Teaching

1.4

6.7

272

1934

CKC12

NOMESCO Finland

Photocoagulation of retina

1.8

6.7

537

7058C

ICD-9 Finland

Disorders of sweat glands, Other specified disorders of sweat glands[HIDRADENITIS SUPPURATIVA]

22.5

6.7

R74

ICPC

Upper respiratory infection acute

1.2

6.7

917

7796

H13

ICPC

Plugged feeling ear

1.4

6.7

335

2481

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

6.7

284

2042

J01DC02

ATC

cefuroxime; systemic

1.6

6.6

150

932

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.9

6.6

441

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

6.6

116

671

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.4

6.6

353

2639

M04AA01

ATC

allopurinol; systemic

1.5

6.6

192

1272

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.4

6.6

223

D10AF01

ATC

clindamycin; topical

1.6

6.6

169

1087

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.1

6.6

112

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

6.6

244

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

12.3

6.6

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

6.6

175

1139

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

6.6

173

1119

K04.08

ICD-10 Finland

Other specified pulpit

1.5

6.5

222

1524

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

6.5

246

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

6.5

396

3025

ZXA00

NOMESCO Finland

Right side

1.3

6.5

515

4089

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

6.5

845

7140

L03.8

ICD-10 Finland

Cellulitis of other sites

6.2

6.5

L73.8

ICD-10 Finland

Other specified follicular disorders

3.1

6.4

103

Z50.1

ICD-10 Finland

Other physical therapy

1.8

6.4

105

596

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

6.4

206

1396

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

6.4

167

1081

H36.01

ICD-10 Finland

Diabetic maculopathy

2.8

6.4

137

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.4

250

1766

9473

FHL

Local soft tissue removal or exploration (eg Bursa)

4.1

6.4

J01CA08

ATC

pivmecillinam; oral

1.3

6.4

716

5947

KMAK

NOMESCO Finland

1.2

6.4

1699

15414

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

6.4

394

SPAT1229

SPAT

Assessment of need for aid

1.7

6.3

110

637

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

6.2

445

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.4

6.2

313

2315

ZZA00

NOMESCO Finland

Split skin graft

2.3

6.2

227

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

6.2

174

1147

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

6.2

271

1960

P72

ICPC

Schizophrenia

2.1

6.2

333

SFA00

NOMESCO Finland

Small filling

1.4

6.1

330

2469

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

5.3

6.1

N30.0

ICD-10 Finland

Acute cystitis

1.5

6.1

223

1554

ZXC10

NOMESCO Finland

Use of laser

2.3

6.1

233

WX702

NOMESCO Finland

Supraglottic ventilation device

1.7

6.1

127

774

SPAT1234

SPAT

Support of social functional capacity

1.9

6.1

441

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.5

6.1

177

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

6.1

195

1320

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.5

6.1

L28

ICPC

Limited function/disability (L)

1.5

6.1

221

1542

C07AB03

ATC

atenolol; systemic

2.0

6.1

365

K60

ICD-10 Finland

Fissure and fistula of anal and rectal regions

8.6

6.0

N49.9

ICD-10 Finland

Inflammatory disorder of unspecified male genital organ

10.0

6.0

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

6.0

164

1071

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

789

3518

2.55

108.21

2.3

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

662

3070

2.39

81.39

1.9

1.6

—

(3012516) Albumin [Mass/volume] in Urine

991

6697

1.64

36.55

3.8

3.3

mg/l

179.5

349.5

1.18

679

4537

(3020682) Albumin/Creatinine [Ratio] in Urine

1020

7013

1.61

34.80

4.7

4.1

mg/mmol

13.4

8.9

1.66

694

4798

(3009508) Creatinine [Moles/volume] in Urine

1143

8129

1.57

33.57

3.8

3.2

mmol/l

8.6

9.0

1.80

979

7068

(3019550) Sodium [Moles/volume] in Serum or Plasma

3406

30864

1.78

32.30

15.0

11.3

mmol/l

139.6

139.7

0.76

3329

30072

(3023103) Potassium [Moles/volume] in Serum or Plasma

3418

31028

1.78

31.89

15.1

11.3

mmol/l

4.0

4.15

3337

30170

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2526

21539

1.48

29.26

7.9

6.8

u/l

77.3

74.5

2.74

2397

20471

(3023368) Bacteria identified in Blood by Culture

891

6163

1.58

28.80

4.5

4.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3086

27505

1.57

28.39

6.0

4.4

mmol/mol

40.8

38.4

26.47

2942

26156

(3024561) Albumin [Mass/volume] in Serum or Plasma

1403

10723

1.48

28.28

5.6

5.0

g/l

36.5

37.0

2.50

1315

10045

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1365

10510

1.46

25.90

3.3

3.2

u/l

31.2

34.0

0.94

1296

10003

(3013826) Glucose [Moles/volume] in Serum or Plasma

1934

15909

1.42

25.44

5.7

4.5

mmol/l

7.0

6.5

10.40

1812

14660

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1705

13752

1.42

24.83

5.7

5.8

umol/l

10.5

11.5

1.88

1625

13044

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3452

31889

1.68

24.33

14.4

10.5

mg/l

22.7

21.8

0.75

2888

24317

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1122

8501

1.45

22.47

3.3

2.5

u/l

52.4

57.2

1.50

1042

7931

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1465

11760

1.39

20.76

7.8

6.5

mmol/l

1.2

0.40

1236

9994

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3041

27703

1.43

18.91

4.8

4.1

mu/l

1.8

2.2

2.21

2870

26058

(3013707) Erythrocyte sedimentation rate by Westergren method

2421

21286

1.36

18.33

4.2

3.6

mm/h

10.4

8.8

7.51

2271

20034

(3026493) Urate [Moles/volume] in Serum or Plasma

957

7301

1.41

17.70

2.5

2.4

umol/l

350.9

3773.7

14.17

864

6588

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2567

22898

1.35

16.92

4.1

3.5

pmol/l

14.6

14.5

0.14

2399

21297

(3013650) Neutrophils [#/volume] in Blood by Automated count

1972

16934

1.33

16.82

11.9

9.1

e9/l

4.4

4.0

13.07

1733

14907

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1303

10531

1.36

16.74

7.1

5.9

mmol/l

1.2

0.31

1206

9663

(42870588) Differential panel, method unspecified - Blood

1197

9557

1.36

16.61

7.5

6.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1576

13134

1.33

16.39

4.2

3.8

—

(3032080) INR in Blood by Coagulation assay

1188

9515

1.36

16.04

8.0

6.8

inr

1.2

1.17

372

2994

(3013115) Eosinophils [#/volume] in Blood

1806

15459

1.31

15.12

8.1

6.4

e9/l

0.2

0.15

1628

13816

(3006315) Basophils [#/volume] in Blood

1748

14902

1.31

15.05

7.7

6.1

e9/l

0.0

1.08

1545

13102

(3001604) Monocytes [#/volume] in Blood

1744

14864

1.31

15.04

7.6

6.1

e9/l

0.6

8.23

1547

13081

(3019198) Lymphocytes [#/volume] in Blood

1803

15451

1.31

14.88

7.7

6.1

e9/l

2.1

2.0

1.99

1636

13867

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1333

10961

1.33

14.79

2.6

2.2

nmol/l

69.3

72.3

3.58

1232

10223

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

946

7388

1.37

14.79

2.5

2.2

u/l

218.7

269.0

0.91

898

7021

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

392

2.46

14.77

21.5

21.3

nmol/l

1461.4

1401.7

0.31

382

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

244

1436

1.75

14.41

3.4

3.2

kpa

5.2

5.1

0.83

231

1345

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

516

3639

1.48

14.28

1.9

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1155

9349

1.33

14.16

3.3

2.8

ng/l

205.1

44.4

0.47

655

5107

(3009343) pH of Capillary blood

241

1423

1.74

14.07

3.4

3.2

7.4

0.30

181

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1147

9301

1.33

13.82

1.9

1.8

pmol/l

97.4

97.2

0.04

662

5250

(3002030) Lymphocytes/100 leukocytes in Blood

1709

14634

1.30

13.82

7.6

6.1

28.9

29.2

0.57

1622

13857

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

233

1376

1.74

13.60

3.3

3.2

mmol/l

1.2

1.4

0.39

181

1007

(3006504) Eosinophils/100 leukocytes in Blood

1635

13957

1.29

13.40

7.6

6.2

2.6

2.8

3.54

1558

13168

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3159

29455

1.37

13.28

12.0

9.3

ml/min/173m2

93.8

91.9

5.61

2637

24197

(3019069) Monocytes/100 leukocytes in Blood

1644

14058

1.29

13.25

7.9

6.4

8.3

8.5

2.66

1570

13343

(3037467) Urinalysis macro (dipstick) panel - Urine

2210

19641

1.29

13.07

4.2

3.5

—

(3018010) Neutrophils/100 leukocytes in Blood

1680

14425

1.29

13.04

7.3

5.9

57.1

56.3

2.30

1605

13697

(3022096) Basophils/100 leukocytes in Blood

1585

13524

1.29

12.87

7.7

6.2

0.7

1.32

1505

12781

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3595

34354

1.55

12.82

10.6

8.4

u/l

31.7

30.1

4.15

3513

33454

(3044889) 12 lead EKG panel

2224

19859

1.28

12.31

3.3

3.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

136

706

1.96

12.02

1.8

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2001

17695

1.27

11.76

4.3

3.5

e6/l

1022.5

879.9

0.06

199

(3009466) Valproate [Moles/volume] in Serum or Plasma

110

535

2.09

11.65

6.0

umol/l

371.8

376.8

0.15

100

476

(3003458) Phosphate [Moles/volume] in Serum or Plasma

439

3118

1.46

11.62

8.1

6.5

mmol/l

1.1

1.0

1.36

415

2940

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

263

1679

1.61

11.41

1.7

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

659

5046

1.37

11.33

1.3

iu/ml

40.0

26.0

0.80

193

1552

(3035350) Ketones [Presence] in Urine by Test strip

1632

14128

1.27

11.31

3.3

2.9

estimate

0.0

1.08

301

2651

(3018095) Leukocytes [#/volume] in Urine

1121

9290

1.29

11.01

3.6

3.2

e6/l

33.6

57.9

2.38

791

6370

(40761511) CBC panel - Blood by Automated count

3544

33924

1.45

10.86

13.3

9.7

—

(3018418) pH of Serum or Plasma

855

6846

1.32

10.83

4.8

3.9

7.4

0.41

173

1362

(3000850) Epithelial cells [#/volume] in Urine

673

5212

1.35

10.71

2.6

2.4

e6/l

5.1

5.4

0.26

603

4596

(3021601) Nitrite [Presence] in Urine by Test strip

1624

14118

1.26

10.65

4.5

4.1

estimate

0.0

0.50

316

2762

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2645

24338

1.27

10.43

3.6

2.9

u/l

51.2

44.5

4.08

2540

23341

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

611

4687

1.36

10.31

1.3

u/ml

9.5

0.00

258

1999

(3009261) Glucose [Presence] in Urine by Test strip

1634

14256

1.25

10.26

3.4

2.9

estimate

0.0

1.47

289

2630

(3044640) Blood type and Crossmatch panel - Blood

1012

8349

1.29

10.15

2.7

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

964

7907

1.29

10.11

3.2

3.1

mmol/l

2.3

0.29

875

7130

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3359

31935

1.36

10.04

4.6

3.9

mmol/l

2.9

2.59

3179

30315

(3002032) Base excess in Venous blood by calculation

305

2076

1.51

9.97

4.7

4.0

mmol/l

1.5

1.9

0.96

244

1667

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3111

29265

1.30

9.96

4.3

3.6

mmol/l

6.1

5.8

24.31

2940

27478

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

816

6561

1.31

9.93

1.9

1.8

mg/l

1.0

0.10

610

4769

(3026782) Osmolality of Urine

628

4866

1.35

9.90

2.7

2.5

mosm/kgh2o

563.4

575.5

0.66

550

4172

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3336

31702

1.35

9.85

4.3

3.7

mmol/l

4.7

5.54

3176

30281

(3019060) Gas panel - Arterial blood

220

1396

1.61

9.81

4.7

5.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3222

30473

1.32

9.77

3.9

3.4

mmol/l

1.5

1.3

13.92

3058

28976

(3021447) Carbon dioxide [Partial pressure] in Venous blood

305

2087

1.50

9.72

4.7

4.0

kpa

5.9

0.22

297

2028

(3002582) Erythrocytes [#/volume] in Urine

945

7773

1.28

9.63

3.1

2.8

e6/l

49.0

104.4

1.51

737

5883

(3012095) Magnesium [Moles/volume] in Serum or Plasma

527

3999

1.37

9.49

3.7

3.6

mmol/l

0.8

0.80

503

3785

(3022217) INR in Platelet poor plasma by Coagulation assay

351

2482

1.45

9.48

18.1

15.7

inr

1.2

0.01

398

(3048689) Calprotectin [Mass/mass] in Stool

563

4324

1.35

9.38

3.1

2.7

ug/g

127.7

128.8

0.03

452

3547

(3027801) Oxygen [Partial pressure] in Arterial blood

359

2558

1.44

9.31

9.2

8.6

kpa

11.9

13.1

4.92

350

2446

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

359

2559

1.44

9.29

9.2

8.6

kpa

5.2

5.1

0.83

351

2444

(3026008) Bacteria identified in Urine by Culture

730

5839

1.31

9.16

2.9

2.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

655

5168

1.32

9.06

2.6

2.9

ng/l

1386.1

974.2

0.62

511

4198

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

344

2446

1.45

9.03

1.8

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

783

6333

1.30

9.02

2.6

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

859

7034

1.28

8.99

3.0

2.8

e6/l

0.3

0.22

656

5191

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

188

1175

1.63

8.94

1.7

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

881

7241

1.28

8.94

1.8

1.6

mmol/l

1.7

1.5

2.85

753

6331

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

141

817

1.75

8.89

2.3

2.5

ug/l

461.0

472.7

0.02

135

761

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

349

2496

1.44

8.88

1.8

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

554

4279

1.34

8.87

1.4

titre

623.3

507.3

0.47

761

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3313

31553

1.32

8.84

4.2

3.6

mmol/l

1.3

1.4

38.93

3145

30059

(3019309) Folate [Moles/volume] in Red Blood Cells

475

3587

1.37

8.79

1.8

1.7

nmol/l

1087.6

1144.6

0.81

382

2828

(3021960) Folate [Moles/volume] in Serum or Plasma

630

4964

1.32

8.78

1.5

1.4

nmol/l

18.5

19.8

1.60

568

4409

(3003396) Base excess in Arterial blood by calculation

355

2552

1.43

8.78

9.3

8.6

mmol/l

0.9

0.06

289

1965

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

735

5919

1.30

8.73

2.1

1.8

1.4

0.45

657

5346

(3016502) Oxygen saturation in Arterial blood

320

2259

1.45

8.72

9.5

9.3

95.1

96.3

1.94

311

2180

(3015235) Bicarbonate [Moles/volume] in Capillary blood

103

545

1.91

8.71

3.0

2.8

mmol/l

24.5

24.6

0.12

480

(3013512) EKG study

797

6513

1.28

8.41

3.6

3.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

161

984

1.66

8.38

3.1

3.2

mmol/l

25.2

0.11

156

952

(3019150) Specific gravity of Urine by Refractometry

746

6072

1.28

8.10

4.0

3.1

kg/l

1.0

0.52

113

851

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

612

4865

1.31

7.96

1.7

1.6

pmol/l

75416310.2

35103320.6

0.66

541

4276

(3021589) Normoblasts [#/volume] in Blood

1509

13308

1.22

7.90

10.1

8.4

e9/l

0.0

1.51

1249

10971

(3014576) Chloride [Moles/volume] in Serum or Plasma

396

2959

1.38

7.82

8.3

7.6

mmol/l

104.3

104.5

0.53

389

2903

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

389

2902

1.38

7.76

3.9

3.6

28.8

30.1

1.50

288

2148

(3023520) Reticulocytes [#/volume] in Blood

230

1562

1.50

7.64

3.7

2.7

e9/l

77.6

71.7

1.46

170

1163

(3022313) Gas panel - Capillary blood

166

1048

1.61

7.63

3.5

3.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

203

1358

1.52

7.26

1.5

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

295

2126

1.42

7.21

10.2

9.7

g/l

129.2

126.7

1.09

287

2045

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

101

567

1.80

7.16

1.1

iu/ml

53.4

930.9

0.52

147

(3036481) Cortisol [Moles/volume] in Serum or Plasma

367

2749

1.37

7.14

2.2

2.1

nmol/l

363.0

372.1

0.40

339

2534

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

104

590

1.78

7.13

2.6

2.5

ug/min

103.3

121.6

0.13

401

(36304419) Bacteria [Presence] in Urine

844

7067

1.25

7.13

3.0

2.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

432

3319

1.34

7.12

3.4

2.4

22.9

25.1

2.51

373

2887

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

173

1125

1.56

7.04

1.7

1.6

iu/ml

0.4

0.2

0.26

213

(3007461) Platelets [#/volume] in Blood

3769

36850

1.56

7.00

21.7

15.4

e9/l

256.6

252.1

4.30

3710

36060

(3014111) Lactate [Moles/volume] in Serum or Plasma

288

2080

1.42

6.96

9.3

8.1

mmol/l

1.4

0.24

279

1997

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1291

11321

1.21

6.93

3.4

2.9

—

(3019225) pH of Specimen

292

2118

1.41

6.89

3.8

3.7

—

(1616796) Gas panel - Central venous blood

545

1.80

6.88

3.2

3.3

—

(3035941) MCH [Entitic mass]

3772

36900

1.55

6.82

21.5

15.3

30.2

0.09

3739

36518

(3024731) MCV [Entitic volume]

3772

36903

1.55

6.78

21.5

15.3

90.1

89.9

1.90

3739

36522

(40758558) Short blood count panel - Blood

843

7096

1.24

6.74

8.3

6.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

731

6058

1.25

6.73

3.4

3.0

—

(3010813) Leukocytes [#/volume] in Blood

3773

36922

1.55

6.69

21.7

15.4

e9/l

7.1

6.7

29.48

3700

36065

(3029937) Albumin [Presence] in Urine by Test strip

865

7308

1.24

6.68

3.8

3.2

estimate

0.0

2.17

300

2654

(3026361) Erythrocytes [#/volume] in Blood

3772

36912

1.54

6.66

21.6

15.4

e12/l

4.7

1.51

3699

36062

(3024354) Oxygen [Partial pressure] in Venous blood

243

1716

1.44

6.66

3.6

3.3

kpa

5.0

4.8

0.49

235

1665

(3027945) Reticulocytes/100 erythrocytes in Blood

305

2245

1.39

6.61

3.3

2.7

1.7

0.01

275

2023

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

214

1477

1.47

6.60

5.7

4.4

ng/l

104.7

83.6

1.68

195

1355

(3000963) Hemoglobin [Mass/volume] in Blood

3773

36932

1.54

6.56

21.8

15.4

g/l

141.5

140.9

1.37

3741

36542

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

568

1.76

6.56

1.5

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

202

1384

1.48

6.47

6.8

7.6

mmol/l

24.7

24.4

0.72

193

1289

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

127

785

1.64

6.41

2.0

ug/l

1.1

2.0

0.85

113

714

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

325

2430

1.37

6.40

3.3

2.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.04

6.34

2.4

2.2

umol/l

16.3

15.4

0.15

(3033658) Prothrombin time (PT) actual/Normal

846

7168

1.23

6.32

4.5

3.9

93.2

0.03

823

6999

(3020891) Body temperature

141

899

1.59

6.28

3.9

4.6

—

(3000494) Fungus identified in Specimen by Culture

432

3385

1.31

6.20

1.5

1.4

—

(3002256) Pathology report gross observation

423

3306

1.31

6.19

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

138

882

1.59

6.10

1.4

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

479

3820

1.29

6.02

3.2

2.8

mmol/l

2.4

0.77

416

3361

(3021901) Oxygen saturation in Capillary blood

378

1.89

6.01

2.8

2.5

—

(3011288) Drugs identified in Urine by Screen method

241

1733

1.42

6.00

3.4

3.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

268

2.07

5.98

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

859

7345

1.22

5.82

1.4

1.3

u/ml

1.3

1.7

0.55

256

2080

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

407

3196

1.31

5.75

2.5

2.9

umol/l

8.5

7.4

0.32

334

2779

(3022948) Iron [Moles/volume] in Serum or Plasma

485

3907

1.28

5.63

3.2

2.4

umol/l

13.6

14.7

2.27

462

3656

(3000991) Gas panel - Venous blood

264

1951

1.38

5.62

11.8

9.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

249

1824

1.39

5.59

3.6

4.5

ug/l

14.2

22.6

0.53

187

1440

(3017143) Hepatitis C virus Ab [Presence] in Serum

623

5172

1.24

5.58

1.8

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

448

3577

1.28

5.58

3.3

2.4

g/l

2.4

0.05

418

3343

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

318

1.93

5.53

1.7

1.5

—

(3017732) Neutrophils [#/volume] in Blood

276

2062

1.36

5.49

3.2

2.5

e9/l

4.2

4.1

0.41

235

1744

(3025468) Yersinia sp identified in Specimen by Organism specific culture

312

1.94

5.48

1.6

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

248

1823

1.38

5.46

1.8

g/l

1.3

0.18

222

1708

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

313

1.93

5.44

1.7

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

928

8049

1.20

5.36

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

332

2571

1.32

5.20

4.0

4.5

u/l

225.3

233.7

0.59

309

2452

(3007164) IgA [Mass/volume] in Serum or Plasma

765

6535

1.21

5.18

1.5

1.4

g/l

2.3

2.4

0.17

516

4375

(3005719) IgG [Mass/volume] in Serum or Plasma

313

2406

1.33

5.17

2.5

g/l

10.6

0.12

278

2225

(3004809) Band form neutrophils/100 leukocytes in Blood

356

1.84

5.10

3.4

3.5

1.3

1.2

0.12

293

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

314

1.89

5.06

1.7

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

315

1.89

5.02

1.7

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

315

1.89

5.02

1.7

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

570

4744

1.24

4.97

3.8

3.2

ng/l

321.3

552.5

0.98

364

3126

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

139

937

1.50

4.90

2.1

1.9

—

(3022145) Colonoscopy Study observation

391

3123

1.28

4.87

1.5

1.4

—

(4010399)

245

1833

1.36

4.86

1.4

—

(40768804) Tissue Pathology biopsy report

1223

10954

1.17

4.76

2.0

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

209

1532

1.38

4.72

1.6

1.4

u/l

6.0

7.5

2.81

178

1250

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

503

1.66

4.63

1.4

mmol/l

7.0

6.8

0.19

374

(3014007) Fractional oxyhemoglobin in Arterial blood

198

1445

1.39

4.60

11.8

10.8

93.4

94.3

1.20

198

1437

(3017354) Segmented neutrophils/100 leukocytes in Blood

213

2.03

4.56

2.9

3.6

54.5

55.9

0.11

152

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

635

1.57

4.41

3.9

3.6

u/ml

0.3

0.08

339

(40768797) Stomach Pathology biopsy report

434

3553

1.25

4.40

1.2

—

(3042517) Benzodiazepines panel - Urine

3.01

4.39

1.5

2.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

276

2136

1.31

4.38

10.6

8.3

mmol/l

9.5

8.3

2.11

266

2051

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

176

2.11

4.37

1.7

iu/ml

5813333.2

1434049.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

100

2.51

4.37

2.1

2.6

umol/l

33.1

29.0

0.53

(3017181) Myelocytes/100 leukocytes in Blood

292

2279

1.30

4.36

5.2

4.5

0.9

0.09

580

(3052851) Hemolysis interference index of Serum or Plasma

109

717

1.54

4.35

3.8

3.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

333

2651

1.28

4.27

2.8

2.6

u/l

36.9

57.4

0.59

285

2318

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

124

843

1.49

4.25

2.0

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

233

1.94

4.24

3.7

4.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

279

2173

1.31

4.24

5.3

4.6

0.0

0.1

2.87

535

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

563

1.59

4.22

1.4

1.5

—

(3037756) Immunofixation for Serum or Plasma

349

1.76

4.22

1.9

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

270

2096

1.31

4.20

2.6

2.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

212

1589

1.35

4.20

2.3

g/l

66.2

67.4

1.75

199

1492

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

290

2276

1.30

4.16

2.8

2.4

g/l

0.2

2.93

274

2121

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

147

1039

1.43

4.13

3.4

3.0

0.6

0.7

0.66

142

1000

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

578

1.57

4.02

1.4

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.94

4.00

2.1

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

124

855

1.46

3.98

1.9

1.6

g/l

0.2

0.48

118

812

(3004588) Protein electrophoresis panel - Serum or Plasma

169

1237

1.38

3.90

2.2

2.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

104

699

1.50

3.80

1.5

1.4

ug/g

283.0

296.2

0.26

394

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

445

1.63

3.79

3.6

3.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

660

1.51

3.77

2.1

2.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

191

1435

1.35

3.76

12.1

10.8

0.7

0.50

191

1424

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

317

1.75

3.75

1.2

—

(3010421) pH of Blood

101

678

1.50

3.72

3.9

3.7

7.4

0.51

566

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

497

4212

1.21

3.62

2.6

2.5

e6/l

1.1

1.0

0.23

268

2285

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1148

10407

1.15

3.61

3.6

3.5

ug/l

1.5

1.8

2.08

1063

9563

(3037121) Protein [Mass/volume] in Urine

128

907

1.43

3.59

3.6

3.5

g/l

0.5

0.3

0.61

450

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

125

885

1.43

3.53

1.9

1.6

g/l

1.2

0.33

120

844

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

233

1820

1.30

3.51

2.7

2.5

u/l

2720.8

5687.1

1.90

734

(4146454)

214

1.88

3.48

3.0

2.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

664

1.49

3.48

3.5

4.2

mmol/l

3.9

0.24

628

(3006184) Hemoglobin [Mass/volume] in Capillary blood

503

1.56

3.47

2.3

2.2

g/l

140.3

137.7

0.41

370

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

694

6078

1.17

3.47

2.2

2.1

mg/l

2.9

2.7

1.05

625

5237

(3002179) Metamyelocytes/100 leukocytes in Blood

264

2100

1.28

3.46

5.0

4.3

0.4

0.6

1.82

428

(40761535) Cells panel - Urine sediment

241

1898

1.29

3.42

3.8

3.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

944

8478

1.15

3.37

2.8

2.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

188

1435

1.33

3.36

12.2

10.7

1.7

1.4

1.51

188

1427

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.84

3.35

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

124

886

1.41

3.35

5.8

6.3

1.1

0.9

0.27

118

828

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

449

3800

1.21

3.33

1.7

1.8

—

(3008295) Osmolality of Serum or Plasma

240

1.80

3.30

1.1

1.7

mosm/kgh2o

282.2

285.4

0.41

196

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

228

1792

1.29

3.30

2.2

ug/l

5.4

8.8

2.66

199

1625

(3047181) Lactate [Moles/volume] in Blood

110

773

1.44

3.26

6.3

6.9

mmol/l

1.2

0.28

664

(3028707) Methadone [Presence] in Urine by Screen method

144

1061

1.37

3.25

3.7

2.8

—

(3012501) Base excess in Blood by calculation

577

1.50

3.23

3.8

3.7

mmol/l

2.5

2.2

0.40

366

(3020191) Ethanol [Moles/volume] in Serum or Plasma

348

1.65

3.20

2.0

1.5

promille

1.6

1.4

0.26

268

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

228

1.81

3.19

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.34

3.19

6.5

9.3

mmol/l

6.9

6.2

0.19

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

372

1.62

3.18

1.4

1.3

nmol/l

0.1

0.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

499

1.53

3.16

2.8

3.2

ratio

3.0

2.6

0.08

(3024139) IgG subclass 3 [Mass/volume] in Serum

334

1.66

3.16

1.4

1.3

g/l

0.5

0.4

1.26

224

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

229

1.80

3.15

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

2856

27538

1.14

3.15

17.5

12.9

13.6

13.4

3.87

2811

27006

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

156

1171

1.35

3.14

6.0

4.5

mmol/l

24.0

24.2

0.38

136

1071

(3028192) IgG subclass 2 [Mass/volume] in Serum

335

1.65

3.12

1.4

1.3

g/l

3.5

3.1

0.74

226

(3027135) IgG subclass 1 [Mass/volume] in Serum

335

1.65

3.12

1.4

1.3

g/l

6.4

0.01

226

(3028300) Cannabinoids [Presence] in Urine

330

2727

1.23

3.12

2.4

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

165

1251

1.33

3.11

12.9

12.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

223

1.80

3.10

1.0

1.1

u/l

63.1

57.0

0.36

153

(3000764) Benzodiazepines [Presence] in Urine

327

2704

1.23

3.07

2.5

2.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

800

7146

1.15

3.06

1.7

—

(3016879) Cocaine [Presence] in Urine

309

2542

1.23

3.05

2.5

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

232

1847

1.27

3.05

3.5

3.3

mmol/l

1.2

0.12

204

1618

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

424

1.57

3.03

1.2

u/l

18.2

37.2

1.37

362

(4062490)

338

1.64

3.03

1.4

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

465

3984

1.19

3.02

2.8

2.6

e6/l

5.0

2.0

1.44

233

2062

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.31

3.00

1.9

2.4

—

(3045424) Erythrocytes [Presence] in Urine

450

1.54

2.98

1.3

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

162

1.92

2.94

1.8

2.1

mg/l

7.6

9.2

0.85

129

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

123

901

1.38

2.92

5.8

6.2

2.0

1.8

1.07

118

841

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

509

1.50

2.91

2.8

3.3

mg/l

31.9

43.0

0.49

411

(3034860) Kappa light chains.free [Mass/volume] in Serum

509

1.50

2.91

2.9

3.3

mg/l

49.4

60.2

0.32

410

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

157

1195

1.33

2.91

14.0

11.4

mmol/l

24.2

0.00

147

1133

(3032057) Clostridioides difficile [Presence] in Stool

3.34

2.90

2.0

—

(3027008) Opiates [Presence] in Urine

327

2723

1.22

2.89

2.5

2.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

700

1.42

2.88

1.3

u/ml

30.0

3.1

—

(3044290) Cell count panel - Cerebral spinal fluid

676

1.43

2.86

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

635

1.44

2.85

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

193

1.82

2.83

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

329

1.62

2.83

1.3

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

505

1.49

2.81

2.3

18.1

17.5

0.60

243

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

361

1.59

2.81

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

123

908

1.37

2.79

1.9

g/l

1.5

1.4

0.42

104

787

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

638

1.44

2.78

3.5

2.2

nmol/l

0.9

0.8

0.58

546

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.47

2.78

4.3

5.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

100

714

1.41

2.77

1.3

u/ml

27.3

7.9

0.36

104

(3015171) Extractable nuclear Ab [Units/volume] in Serum

149

1135

1.33

2.76

1.2

u/ml

2.7

0.9

—

(3025159) Blasts/100 leukocytes in Blood

254

2078

1.24

2.67

5.5

4.6

0.1

0.3

0.59

448

(3017446) Testosterone [Moles/volume] in Serum or Plasma

457

3953

1.18

2.67

2.7

2.3

nmol/l

12.2

13.9

5.50

420

3630

(3021879) Hepatitis B virus core Ab [Presence] in Serum

398

3405

1.19

2.65

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

336

1.59

2.62

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

133

1005

1.33

2.62

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

156

1.87

2.56

1.5

1.4

e6/l

25582.2

61027.8

0.67

(3016750) Collection duration of Urine

149

1.89

2.55

2.4

2.3

min

501.6

504.9

0.08

115

(3027944) Amphetamines [Presence] in Urine

319

2685

1.20

2.55

2.4

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1441

13476

1.11

2.53

3.2

2.7

ug/l

135.9

117.0

0.79

1373

12742

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

168

1320

1.28

2.51

2.1

u/l

40.6

39.4

0.30

152

1212

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

179

1.79

2.51

1.3

1.4

71.8

71.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

443

3844

1.17

2.50

2.7

2.2

29.9

29.6

0.55

428

3730

(40760892) CBC W Ordered Manual Differential panel - Blood

824

7470

1.13

2.50

5.4

4.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

721

1.38

2.48

1.6

1.5

e6/l

5187.5

968.8

0.49

596

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

341

1.56

2.48

1.3

1.5

pmol/l

285.1

321.9

0.36

267

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

175

1385

1.28

2.47

2.1

2.0

pmol/l

186.4

213.1

2.56

166

1322

(3014891) Appearance of Pleural fluid

4.38

2.47

2.1

1.4

—

(3004451) EKG impression Narrative

102

2.06

2.47

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

722

1.38

2.46

1.6

1.5

e6/l

26.3

26.5

0.01

571

(3024263) Appearance of Synovial fluid

123

1.96

2.45

1.3

2.0

—

(3008898) HLA-B27 [Presence]

184

1468

1.27

2.44

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

241

1.67

2.44

2.1

2.0

mg/l

24.1

22.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

415

1.50

2.43

1.7

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

417

1.49

2.39

2.4

2.7

mmol/l

1.6

1.5

0.32

406

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.21

2.37

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

154

1.82

2.33

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

602

1.40

2.33

1.2

u/ml

59.9

32.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

345

2955

1.18

2.30

6.7

5.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

208

2534

0.81

2.29

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

496

1.44

2.27

1.9

2.2

g/l

0.0

0.00

472

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

538

1.42

2.27

1.9

2.2

g/l

0.0

0.17

512

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

522

1.43

2.25

1.1

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

294

1.57

2.24

1.8

2.6

47.5

42.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

498

1.43

2.23

1.9

2.2

g/l

0.0

0.49

473

(3030905) Polymorphonuclear cells [#/volume] in Blood

591

1.40

2.22

3.8

3.6

e9/l

4.3

4.1

0.42

591

(3025941) Bacteria identified in Stool by Culture

236

1960

1.22

2.20

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

102

1347

0.75

2.18

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.62

2.18

1.9

2.1

—

(40757373) Influenza virus identified in Isolate

2.62

2.18

1.5

1.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

102

1346

0.75

2.17

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

119

913

1.31

2.17

1.6

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

151

1.79

2.15

2.0

1.9

umol/l

88.5

156.7

0.95

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

102

1344

0.75

2.15

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.30

2.14

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

436

1.45

2.14

1.7

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

102

1341

0.75

2.12

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

118

908

1.31

2.11

1.7

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

178

1442

1.25

2.11

1.3

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

127

988

1.29

2.10

1.0

1.1

u/ml

1.0

5.1

2.77

170

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

112

1451

0.77

2.10

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

224

1861

1.22

2.10

3.2

3.5

pmol/l

4.5

4.6

1.37

208

1673

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.56

2.09

10.5

6.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

505

1.41

2.09

1.2

—

281.3

—

(1002224) Polysomnography panel

239

1999

1.21

2.09

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

340

1.51

2.08

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

677

6134

1.13

2.07

2.0

2.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

390

1.47

2.06

2.9

3.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

341

1.50

2.06

1.4

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

609

1.37

2.05

4.2

3.8

57.4

56.8

0.18

609

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

1.80

2.04

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

270

2291

1.19

2.03

1.3

1.2

iu/ml

139.5

156.4

0.29

106

841

(42529406) Shigella sp [Presence] in Stool by Culture

115

888

1.30

2.02

1.3

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

125

1.84

2.02

1.6

1.8

au/ml

150.0

145.1

—

(3022621) pH of Urine by Test strip

195

1605

1.23

2.01

3.3

2.3

—

(3033799) Differential panel - Peritoneal fluid

2.23

2.00

1.4

2.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

134

1057

1.28

2.00

2.1

2.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

104

1.93

2.00

1.9

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

104

1.93

2.00

1.9

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

599

0.65

1.99

1.3

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

272

3182

0.84

1.98

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

148

1184

1.26

1.98

1.5

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

562

1.38

1.97

1.4

1.7

g/l

0.7

0.8

0.56

431

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.08

1.96

1.4

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

225

1.61

1.96

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

225

1.61

1.96

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

225

1.61

1.96

1.3

1.1

—

(40768806) Pleura Pathology biopsy report

156

1.74

1.96

1.8

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

194

1.65

1.96

3.6

2.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

546

1.38

1.95

1.5

1.6

e6/l

9570.1

13750.4

0.53

395

(3000060) B lymphocytes [#/volume] in Blood

1.94

1.95

1.8

2.0

e6/l

144.4

185.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

589

1.37

1.95

2.0

2.2

g/l

0.3

0.8

1.10

541

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

242

1.58

1.92

1.5

1.3

nmol/l

1.5

1.4

0.44

224

(3001186) Copper [Moles/volume] in Serum or Plasma

2.06

1.90

1.7

1.3

umol/l

16.4

16.6

0.08

(3038515) Glucose [Moles/volume] in Venous blood

389

1.45

1.90

2.5

2.8

mmol/l

6.6

7.2

1.60

382

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

227

1.59

1.90

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

227

1.59

1.90

1.4

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

113

881

1.29

1.87

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

228

1.58

1.87

1.4

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

174

1.67

1.86

1.6

1.4

e6/l

3386.9

3051.6

0.12

119

(3023323) Follitropin [Units/volume] in Serum or Plasma

220

1850

1.20

1.85

1.5

1.4

iu/l

16.1

21.4

2.79

188

1559

(3007566) Smooth muscle Ab [Titer] in Serum

122

963

1.28

1.84

1.2

1.3

titre

66.3

84.2

—

100

(3024928) Oxygen saturation in Venous blood

544

1.37

1.83

4.6

3.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.13

1.81

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

2.13

1.81

3.4

2.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

736

1.31

1.81

1.8

1.9

iu/l

3.5

4.7

1.15

284

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.27

1.80

1.4

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1138

0.76

1.79

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

153

1.70

1.79

1.5

1.4

nmol/l

143.0

138.4

0.22

153

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

564

1.35

1.78

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

191

1592

1.21

1.77

2.4

2.6

ng/l

162.0

125.1

0.58

167

1391

(3026389) Candida sp identified in Specimen by Organism specific culture

370

1.44

1.77

1.5

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

258

2211

1.18

1.76

2.3

au/ml

12.3

21.6

1.97

191

(3000093) Morphology [Interpretation] in Blood Narrative

216

1.58

1.76

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

321

1.47

1.76

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

105

819

1.29

1.75

1.4

mg/l

626.8

503.5

0.87

100

781

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

119

946

1.27

1.71

3.2

2.8

g/l

4.1

3.5

2.17

114

899

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

125

1.76

1.71

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

140

1.72

1.71

2.2

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

398

1.41

1.71

4.4

4.0

u/ml

305.6

236.7

0.18

373

(3005033) Fetal Nuchal fold Thickness US

1106

0.76

1.70

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

111

876

1.27

1.70

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

110

868

1.27

1.69

3.1

3.6

mg/l

1.5

1.3

1.17

817

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1014

0.75

1.68

1.2

1.1

u/ml

0.7

1.6

1.73

421

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

119

949

1.26

1.68

1.2

—

(3045788) Cell count panel - Pleural fluid

141

1.71

1.68

1.7

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

562

1.34

1.67

3.6

2.9

mg/l

20.5

24.6

0.57

353

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

649

1.32

1.67

1.9

2.2

g/l

10.4

0.01

569

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

418

4672

0.88

1.66

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

350

1.43

1.66

1.9

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.16

1.66

2.7

5.2

—

(3007463) Buprenorphine [Presence] in Urine

3.16

1.66

8.0

6.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

443

1.38

1.66

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

268

1.50

1.65

3.4

6.9

mmol/l

8.2

7.1

0.58

223

(3013005) Retinol [Moles/volume] in Serum or Plasma

127

1.74

1.64

1.3

2.0

umol/l

1.9

2.0

0.39

120

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.34

1.64

2.0

2.2

g/l

37.0

38.5

1.19

494

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

277

1.49

1.63

1.2

1.3

titre

38.0

247.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1110

0.77

1.63

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

626

1.32

1.62

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

661

1.31

1.62

1.9

2.1

g/l

3.3

3.1

0.88

539

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

723

1.29

1.61

1.3

mmol/l

3.9

3.7

0.99

681

(40761536) Microorganisms panel - Urine sediment

287

2501

1.16

1.61

3.5

3.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

733

6767

1.10

1.60

2.1

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

217

1852

1.18

1.59

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

136

1.70

1.58

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

180

1512

1.20

1.57

1.5

1.4

—

(3044941) Cell count panel - Synovial fluid

363

1.41

1.57

1.5

1.4

—

(3020491) Glucose [Moles/volume] in Blood

239

1.51

1.57

2.5

1.6

mmol/l

7.3

6.4

0.67

171

(3027923) C peptide [Moles/volume] in Serum or Plasma

160

1.63

1.55

1.4

1.6

nmol/l

1.5

1.4

0.11

124

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

247

2138

1.17

1.53

3.1

2.3

ml/min/173m2

74.0

76.8

0.35

734

(3011412) CD3 cells [#/volume] in Blood

298

1.45

1.53

2.4

2.7

e9/l

1.3

0.20

170

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

1.80

1.52

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

695

1.29

1.51

1.9

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

695

1.29

1.51

1.9

2.1

g/l

7.4

7.2

0.59

551

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

695

1.29

1.51

1.9

2.1

g/l

4.1

3.9

0.47

523

(3004775) Volume in Urine collected for unspecified duration

185

1.57

1.51

3.0

2.3

609.4

678.1

0.51

133

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2705

26388

1.08

1.48

3.5

3.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

259

1.47

1.48

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

353

1.39

1.43

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.31

1.43

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

414

1.36

1.41

1.6

1.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

211

1820

1.17

1.39

1.8

1.7

mu/l

286.2

282.8

0.05

196

1652

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

222

1.49

1.38

2.5

3.0

e9/l

0.2

0.20

194

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.94

1.38

7.5

10.9

—

(3025315) Body weight

2.61

1.36

4.2

2.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

127

1.66

1.36

1.9

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

256

1.45

1.35

1.4

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.83

1.35

2.0

1.4

ug/l

9.0

8.4

0.23

(3003338) MCHC [Mass/volume]

3038

29814

1.08

1.34

18.2

13.0

g/l

334.4

334.9

2.06

3012

29599

(3003888) Timothy IgE Ab [Units/volume] in Serum

922

0.78

1.34

1.1

u/ml

6.8

6.7

0.02

494

(3008401) Mugwort IgE Ab [Units/volume] in Serum

888

0.77

1.33

1.1

u/ml

0.6

1.2

1.22

378

(3010726) Horse dander IgE Ab [Units/volume] in Serum

888

0.77

1.33

1.1

u/ml

1.4

2.2

0.51

216

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

128

1.64

1.33

1.9

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

235

2053

1.15

1.32

1.3

au/ml

40.5

56.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

266

1.43

1.32

1.3

1.1

—

(40768446) Kidney Pathology biopsy report

144

1.60

1.31

1.8

1.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

292

1.41

1.30

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.78

1.28

1.4

2.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

218

1.47

1.28

1.9

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

733

1.25

3.2

4.1

u/ml

2157.0

2015.0

0.02

642

(3024891) Influenza virus A+B Ag [Presence] in Specimen

118

978

1.21

1.24

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

270

1.41

1.23

1.6

1.7

—

(3024932) HLA-DR beta [Type]

131

1.61

1.23

1.0

1.1

—

(3024471) HLA-A [Type]

131

1.61

1.23

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

381

1.34

1.23

1.5

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.00

1.23

1.4

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

196

1.48

1.21

2.1

1.4

u/l

6.0

7.6

0.77

166

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

116

1.64

1.21

1.8

2.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

487

1.30

1.21

1.1

g/l

1.5

0.84

445

(46235355) HIV 1 and 2 tests - Meaningful Use set

968

9157

1.08

1.20

2.0

—

(40768441) Liver Pathology biopsy report

205

1.47

1.19

1.4

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.83

1.19

1.8

2.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

524

1.28

1.18

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

126

1058

1.20

1.17

2.8

2.4

94.8

92.8

0.39

117

978

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

101

830

1.22

1.17

2.4

2.1

mg/l

10.1

10.3

0.10

784

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

206

1.46

1.17

3.4

3.3

mg/l

10.2

8.2

0.81

176

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

874

8250

1.08

1.15

3.3

3.1

21.2

21.3

0.03

297

2935

(4035726)

227

2002

1.14

1.15

1.3

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

807

1.22

1.12

1.5

1.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.00

1.12

1.0

1.1

—

(3045716) Anion gap in Serum or Plasma

111

1.62

1.12

3.6

2.7

mmol/l

9.1

9.2

0.06

(3033705) Calcium.ionized [Moles/volume] in Venous blood

217

1.43

1.11

2.5

2.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

319

1.35

1.11

1.5

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

601

1.25

1.10

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

565

5250

1.09

1.10

1.5

1.4

—

(3021788) Differential panel - Synovial fluid

433

1.30

1.09

1.5

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

692

1.23

1.09

6.6

5.8

iu/ml

658.9

680.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

121

1021

1.19

1.09

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

460

1.29

1.09

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

460

1.29

1.09

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.19

1.08

1.4

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

227

1.41

1.07

2.6

2.9

e6/l

528.7

564.3

0.12

194

(3045142) Bone marrow Pathology biopsy report

227

1.41

1.07

1.3

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.87

1.07

1.0

1.3

pmol/l

356.8

255.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

578

1.25

1.06

1.2

1.3

u/ml

2.9

4.0

0.44

194

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

186

1.45

1.05

1.4

1.1

miu/ml

1787.6

1431.5

0.82

186

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

614

1.24

1.05

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

570

1.25

1.04

1.2

—

(3036489) Thrombin time

138

1183

1.17

1.04

2.8

2.3

21.6

21.1

0.42

119

1014

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

654

6130

1.08

1.04

2.3

2.4

ug/l

0.6

0.7

1.01

327

3217

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

121

1026

1.19

1.04

3.7

2.4

u/ml

24.7

42.1

1.72

114

984

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

419

1.29

1.04

1.8

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

297

1.35

1.04

3.9

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

517

1.26

1.03

1.5

1.4

pmol/l

126.8

96.6

0.17

505

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.27

1.03

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

122

1.56

1.02

1.4

1.5

—

(4281824)

171

1.46

1.02

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

139

1196

1.17

1.01

2.0

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

564

1.25

1.01

1.2

1.1

125.1

114.3

1.67

522

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

335

1.32

0.98

1.3

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

158

0.57

0.98

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.95

0.97

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

258

1.36

0.96

1.7

2.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

704

0.79

0.96

1.1

u/ml

15.7

4.8

0.42

287

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

124

1.53

0.96

1.4

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

116

1.55

0.96

1.9

2.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

116

1.55

0.96

1.9

2.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

116

1.55

0.96

1.9

2.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

108

1.58

0.96

1.2

31.5

17.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

182

1.43

0.95

38.2

33.9

ug/l

8.2

7.4

1.26

170

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.78

0.94

1.0

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

150

1.47

0.92

1.3

1.1

iu/ml

122.0

201.3

1.47

150

(3003694) ABO and Rh group [Type] in Blood

1010

9655

1.06

0.92

1.5

—

(3017704) Immunofixation for Urine

102

1.57

0.90

1.7

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

245

1.35

0.88

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

0.88

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

946

0.83

0.88

1.5

—

(3028433) Virus identified in Specimen by Culture

1.61

0.87

1.0

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

102

869

1.18

0.87

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

203

1.38

0.87

1.6

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

203

1.38

0.87

1.6

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

203

1.38

0.87

1.6

1.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

104

1214

0.85

0.87

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.00

0.87

1.0

1.2

—

(36660697) Celiac disease serology panel - Serum

285

2602

1.10

0.86

1.2

—

(3023410) Appearance of Cerebral spinal fluid

326

1.29

0.85

2.0

1.7

—

(3000492) Spirometry study

405

3762

1.09

0.84

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

606

1.21

0.83

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

972

0.84

0.83

1.6

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

292

1.30

0.83

1.3

1.4

mmol/l

13.2

11.9

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.88

0.81

1.3

1.4

16.7

29.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

562

1.21

0.81

1.2

1.3

u/ml

3.4

4.4

0.55

254

(3050129) First trimester maternal screen panel - Serum or Plasma

147

1662

0.88

0.81

1.5

1.4

—

(3013762) Body weight Measured

0.00

0.79

0.0

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

173

1.39

0.78

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

1.53

0.78

1.7

2.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

163

1453

1.13

0.77

1.3

miu/ml

220.8

222.1

0.01

685

(3045414) Leukocytes [Presence] in Urine

128

1124

1.14

0.76

1.5

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

1.77

0.76

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

261

1.31

0.76

2.9

3.0

e6/l

752.2

753.6

0.00

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

107

1.50

0.76

3.5

3.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

3221

31856

1.06

0.76

15.5

11.2

41.6

41.5

0.30

2586

26418

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

595

1.20

0.75

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

235

1.32

0.75

1.8

2.1

12.5

14.3

0.44

119

(3022689) Creatine [Moles/volume] in Urine

1.60

0.74

1.4

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

459

1.22

0.74

3.1

3.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

755

0.83

0.74

1.1

u/ml

4.2

4.3

0.02

299

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.84

0.73

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

142

1.41

0.72

7.3

4.9

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.62

0.71

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

220

1.32

0.71

2.8

2.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

264

1.29

0.71

1.1

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

168

1.37

0.71

1.7

2.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

168

1.37

0.71

1.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.75

0.71

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

194

1.34

0.71

4.5

2.7

nmol/l

0.8

0.9

0.21

140

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

776

1.16

0.70

1.8

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

327

1.26

0.70

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.71

0.70

1.0

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

602

1.18

0.68

1.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.64

0.68

1.0

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.60

0.68

1.2

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

267

1.28

0.66

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.53

0.66

1.2

1.1

—

(4198724)

285

1.27

0.66

2.6

1.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.51

0.66

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.51

0.66

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.51

0.66

2.1

1.2

—

(40768793) Breast Pathology biopsy report

406

0.79

0.65

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

829

1.15

0.65

1.3

1.2

u/ml

240.9

255.4

0.19

536

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.59

0.65

1.4

1.2

mg/l

0.6

331.5

—

(4034850)

100

877

1.14

0.64

9.6

7.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.48

0.64

1.6

2.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.73

0.64

1.6

2.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.73

0.64

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.73

0.64

1.0

u/ml

—

0.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

325

0.77

0.62

1.4

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

199

1.31

0.62

1.2

—

57.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.63

0.62

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.60

0.61

1.0

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

244

1.27

0.61

1.2

1.1

u/l

1.0

1.1

0.18

111

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.60

0.0

1.0

—

30.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

140

0.64

0.60

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

218

1.29

0.60

1.4

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.54

0.59

1.5

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

131

1.38

0.59

2.9

3.0

—

(3019977) pH of Arterial blood

114

1.41

0.58

1.4

2.9

7.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

114

1.41

0.58

1.0

ng/l

229.4

267.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.58

0.0

1.5

—

9.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

327

1.23

0.58

1.7

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.58

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.45

0.55

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

339

1.21

0.54

1.5

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.58

0.54

1.3

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

552

1.16

0.54

1.3

1.4

u/l

18.9

19.2

0.03

465

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.48

0.53

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.48

0.53

1.1

98.6

90.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

125

1.36

0.53

1.9

1.8

—

(4306422)

590

1.16

0.53

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

631

0.85

0.53

1.1

u/ml

0.2

0.4

—

137

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

134

1.34

0.53

1.4

1.9

umol/l

26.9

28.1

0.18

128

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.62

0.52

1.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

221

2376

0.93

0.52

1.8

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

369

1.19

0.51

1.7

1.6

mmol/l

9.3

7.6

0.98

231

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.50

0.51

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

136

0.66

0.51

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

204

1891

1.08

0.51

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

135

1.33

0.51

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

143

1561

0.91

0.49

1.8

1.7

mg/l

4.9

3.5

0.63

115

1043

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.56

0.49

1.3

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.56

0.49

1.3

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

110

1.37

0.48

1.0

ng/l

1139.3

779.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

111

0.63

0.48

1.0

1.2

90.9

110.4

—

104

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

382

1.18

0.47

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

143

0.70

0.47

2.4

1.9

—

(4027681)

290

1.21

0.47

1.4

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.47

0.47

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

282

1.21

0.46

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

221

0.77

0.46

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.38

0.46

1.7

2.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.38

0.46

1.7

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

449

1.16

0.45

1.1

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

187

0.75

0.45

1.1

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.59

0.45

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

103

1.36

0.45

3.6

4.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

292

1.20

0.45

1.1

1.0

u/ml

0.7

1.3

—

(3048879) Bone marrow aspiration report

1.40

0.45

2.0

2.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.40

0.45

7.7

7.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

112

1.34

0.44

1.0

ng/l

23.7

37.4

—

(40758292) HTLV I+II Ab panel - Serum

1.45

0.44

1.2

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.37

0.44

1.0

1.4

nmol/l

0.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

284

1.20

0.43

3.2

5.2

u/ml

16.0

69.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

104

1.35

0.43

3.2

3.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.61

0.43

1.0

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

1.61

0.43

1.4

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

285

1.19

0.42

1.1

1.0

u/ml

2.0

1.6

—

(4268621)

387

1.16

0.42

2.4

2.3

—

(3028717) Thiamine [Mass/volume] in Blood

1.56

0.42

1.4

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

176

1.25

0.41

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.38

0.41

1.3

1.2

—

6.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.41

0.0

1.2

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

507

5268

0.96

0.41

1.7

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.40

0.0

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.40

0.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

114

1.32

0.40

1.7

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

729

1.11

0.40

2.0

1.5

u/ml

100.1

109.2

0.40

147

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.33

0.40

2.0

1.4

—

(21494434) Karyotype in Bone marrow

177

1.24

0.40

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

214

1.22

0.39

2.9

1.8

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.2

—

14.0

—

(40768443) Skin Pathology biopsy report

116

1068

1.09

0.38

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.33

0.37

1.5

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.31

0.37

1.0

ug/l

113.3

79.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

129

1196

1.08

0.36

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

640

1.11

0.36

1.4

1.5

nmol/l

0.4

0.08

524

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

162

1.24

0.35

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

459

0.87

0.35

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

490

0.88

0.34

2.3

2.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

264

1.18

0.34

1.3

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.36

0.34

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

566

1.11

0.34

1.8

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.34

0.34

1.8

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

296

2829

1.05

0.34

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

209

1.20

0.34

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

284

0.84

0.31

2.8

3.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

102

1100

0.93

0.31

1.8

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

156

1.22

0.31

1.2

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

283

0.85

0.30

5.5

6.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

296

1.15

0.30

1.5

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.33

0.30

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.31

0.30

1.3

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.27

0.30

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

278

1.15

0.29

1.1

1.0

u/ml

0.3

2.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

204

1.18

0.28

6.4

8.4

u/ml

35.9

10104.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

104

969

1.08

0.28

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

121

1.24

0.28

1.3

1.4

—

(3003181) Sodium [Moles/volume] in Urine

317

1.14

0.28

1.5

1.4

mmol/l

65.5

70.1

0.21

250

(3011648) Oxygen content in Venous blood

223

1.17

0.28

3.5

3.2

11.6

11.8

0.05

223

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.32

0.28

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.32

0.28

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.32

0.28

1.0

1.1

—

(3035880) pH of Pleural fluid

1.29

0.28

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

202

1925

1.05

0.28

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

177

1.19

0.27

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

118

0.76

0.27

2.7

3.5

u/ml

17.1

59.9

—

118

(3035933) Granulocytes/100 leukocytes in Blood

118

0.76

0.27

1.0

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

290

0.86

0.27

1.8

1.6

49.6

56.8

0.41

181

(3051593) INR in Capillary blood by Coagulation assay

1.21

0.26

11.5

7.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

106

992

1.07

0.26

1.6

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

520

0.90

0.26

1.7

1.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

169

1.18

0.25

1.3

mmol/l

4.7

6.1

1.93

153

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

339

1.12

0.25

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

1.24

0.24

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

580

0.91

0.24

1.2

1.4

pmol/l

50.5

127.7

0.80

175

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.27

0.24

1.3

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

227

1.15

0.23

3.9

3.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

152

1.19

0.23

24.3

22.9

ug/l

148.2

120.8

0.73

125

(3038177) Helicobacter pylori Ab [Presence] in Serum

639

1.08

0.23

1.1

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

1.28

0.23

5.4

3.4

ml/dl

16.2

15.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

162

1.17

0.22

1.2

1.1

—

(4094501)

784

0.93

0.22

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.76

0.22

1.4

2.0

—

(4211845)

124

0.81

0.21

1.4

2.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

124

0.81

0.21

1.1

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.21

0.0

1.0

—

150.7

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.2

—

109.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

1.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

10.8

—

(21494755) Public health laboratory ask at order entry panel

565

5772

0.98

0.21

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

363

1.10

0.21

1.2

mg/l

57.2

41.7

1.26

297

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

126

1.19

0.21

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

211

1.14

0.20

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.25

0.20

1.5

1.6

—

(3025130) Human papilloma virus identified in Specimen

412

1.09

0.20

1.8

1.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.20

0.0

3.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.25

0.20

1.0

1.4

—

(3015183) Erythrocyte sedimentation rate

250

0.88

0.20

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.20

0.19

1.3

1.0

u/ml

1.3

0.9

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.15

0.19

1.3

1.0

u/ml

17.8

0.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

207

0.87

0.19

5.1

4.2

—

(3047189) Immunofixation for 24 hour Urine

1.24

0.18

1.3

2.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

209

2162

0.96

0.18

1.4

1.3

u/ml

380.0

215.5

0.60

199

2011

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

166

1.15

0.18

4.5

7.7

—

(3044007) Cell count panel - Peritoneal fluid

1.15

0.17

2.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.22

0.17

1.2

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.75

0.17

1.0

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.75

0.17

1.0

2.6

—

(4038314)

1.16

0.16

1.6

1.3

—

(40765096) Chromosome analysis panel by Banding

1.11

0.16

1.0

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.10

0.15

2.3

2.0

ug/l

48.5

67.7

—

(3051651) Icteric interference index of Serum or Plasma

168

1.13

0.15

4.7

3.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.14

0.15

3.1

4.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

595

1.06

0.15

1.0

u/ml

4.1

3.1

0.22

343

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.10

0.15

1.4

1.1

u/ml

4.0

8.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

129

0.85

0.14

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

227

1.10

0.14

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

295

0.91

0.14

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

103

1.17

0.13

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

222

0.90

0.13

1.6

1.5

20.3

30.9

1.01

129

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

361

3542

1.02

0.13

2.1

—

(3020650) Glucose [Presence] in Urine

1.16

0.11

1.2

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.16

0.11

1.4

1.3

—

63.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

173

1.10

0.10

1.0

1.1

104.0

95.7

0.60

142

(40768795) Lymph node Pathology biopsy report

241

1.08

0.10

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.11

0.09

1.2

1.0

u/ml

0.0

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.04

0.09

1.2

—

206.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

301

1.06

0.09

2.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

262

1.07

0.09

1.6

1.9

—

(3023419) Bacteria identified in Sputum by Culture

272

1.07

0.09

3.6

2.8

—

(3000012) Reticulocyte production index

1.13

0.09

2.1

1.6

—

(4024509)

165

1.09

0.08

1.2

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

253

1.07

0.08

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

824

1.03

0.08

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.78

0.08

1.0

1.3

55.0

53.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

825

1.03

0.08

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.06

0.08

7.7

6.8

—

(3017509) Phencyclidine [Presence] in Urine

0.83

0.07

3.2

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

147

1.09

0.07

1.5

1.7

—

(4133840)

132

0.91

0.06

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

528

0.97

0.06

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

103

0.87

0.06

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

103

0.87

0.06

1.6

—

(3006462) Nitrate [Presence] in Urine

105

0.86

0.06

1.4

2.5

—

(40768800) Prostate Pathology biopsy report

467

0.96

0.06

1.2

—

(3049717) Cytology report of Urine Cyto stain

721

1.03

0.06

2.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

227

1.06

0.06

2.8

2.7

42.5

43.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

139

1.08

0.05

1.3

1.5

u/l

6.2

4.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

120

1.08

0.04

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

209

1.05

0.04

2.5

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

131

1.07

0.03

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

151

1.06

0.03

2.5

1.9

u/field

1.3

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

442

4399

1.01

0.03

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

209

0.96

0.03

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

102

1033

0.99

0.03

3.1

2.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

591

0.98

0.02

1.7

2.3

umol/l

3.8

5.9

1.41

437

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

212

1.04

0.02

1.1

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

521

1.02

0.02

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

183

1819

1.01

0.01

2.0

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

143

1.05

0.01

1.1

—

(44806118)

323

1.02

0.01

1.9

1.5

—

(44790047)

323

1.02

0.01

1.9

1.5

—

(44790049)

323

1.02

0.01

1.9

1.5

—

(44790048)

323

1.02

0.01

1.9

1.5

—

(1761868) Lipid panel - Serum or Plasma

1403

14018

1.00

0.01

2.6

2.4

—

(3044927) Protein electrophoresis panel - Urine

174

1.03

0.00

1.8

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

226

0.97

0.00

1.4

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

232

0.99

0.00

1.0

1.1

ratio

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

155

0.97

0.00

4.3

2.5

ug/l

18.2

219.8

0.71

142

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

185

0.97

0.00

1.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

205

0.98

0.00

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

245

0.98

0.00

1.3

u/ml

0.2

0.4

0.55

(3034426) Prothrombin time (PT)

139

1.01

0.00

1.1

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

636

1.01

0.00

3.6

2.2

13.0

0.02

630

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

116

1.03

0.00

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

104

0.96

0.00

1.4

2.4

—

(44813793)

237

1.01

0.00

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

223

0.99

0.00

1.3

e6/l

26778.9

92395.4

0.90

161

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

123.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.7

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

1169.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.02

0.00

1.2

1.0

u/ml

0.5

0.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.2

—

(3013637) Mi-2 Ab [Presence] in Serum

0.94

0.00

1.0

1.1

—

(44806071)

1.02

0.00

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.91

0.00

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.00

0.00

7.6

6.7

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.94

0.00

1.0

2.3

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.6

—

6.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.94

0.00

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.94

0.00

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.94

0.00

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.95

0.00

1.2

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_PILONIDALCYST and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_PILONIDALCYST	1.434 [1.18, 1.74]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 6711 females with L12_PILONIDALCYST died.

Males

Parameter	HR [95% CI]	p-value
L12_PILONIDALCYST	1.341 [1.19, 1.51]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 792 out of 18376 males with L12_PILONIDALCYST died.

Mortality risk

Mortality risk for people of age

years, who have L12_PILONIDALCYST.

N-year risk	Females	Males
1	0.127%	0.249%
5	0.809%	1.604%
10	1.803%	3.91%
15	3.667%	7.756%
20	5.968%	12.828%

Relationships between endpoints

↥

Index endpoint: L12_PILONIDALCYST – Pilonidal cyst

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pilonidal cyst

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints